Soc. Generale Discount Zert SAX 2.../ DE000SU2GJ30 /
| 5/23/2024 9:36:59 PM | Chg.+0.090 | Bid5/23/2024 | Ask5/23/2024 | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 53.990EUR | +0.17% | 53.990 Bid Size: 250 |
54.020 Ask Size: 250 |
STROEER SE + CO. KGA... | - - | 9/27/2024 | Call |
GlobeNewswire
11:06 PM
G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (A...
GlobeNewswire
11:05 PM
Updated Phase 1 Clinical Data for SYS-6002 (CRB-701) to be presented at 2024 ASCO Annual Meeting
GlobeNewswire
11:05 PM
BioAtla Presenting Phase 1 Evalstotug Clinical Trial Data Demonstrating Clinical Benefit at the Upco...
GlobeNewswire
11:05 PM
I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at A...
GlobeNewswire
11:05 PM
Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrat...
GlobeNewswire
11:05 PM
FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) ...
GlobeNewswire
11:05 PM
NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Adva...
GlobeNewswire
11:05 PM
Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study i...
GlobeNewswire
11:04 PM
Cullinan Therapeutics to Present First Data for CLN-619, a Novel Anti-MICA/B Antibody, in Combinatio...
GlobeNewswire
11:03 PM
Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Com...
GlobeNewswire
11:01 PM
Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitab...
GlobeNewswire
11:01 PM
Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluatin...
GlobeNewswire
11:01 PM
HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical...
GlobeNewswire
11:00 PM
Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Co...
GlobeNewswire
11:00 PM
Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term E...
GlobeNewswire
11:00 PM
Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual M...
GlobeNewswire
11:00 PM
Merus Announces Publication of Abstracts for Presentation at the 2024 ASCO® Annual Meeting
GlobeNewswire
11:00 PM
MAQUIA CAPITAL ACQUISITION CORPORATION AND IMMERSED INC. MUTUALLY AGREE TO TERMINATE BUSINESS COMBIN...
GlobeNewswire
11:00 PM
Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m...
GlobeNewswire
11:00 PM
Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
